PCN48 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Neoadjuvant Treatment of HER2-Positive EARLY or Locally Advanced Breast Cancer: Update Results after National Drug Reimbursement LIST Adjustment in China